Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
出版年份 2015 全文链接
标题
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
作者
关键词
-
出版物
CRITICAL REVIEWS IN BIOTECHNOLOGY
Volume 36, Issue 6, Pages 1110-1122
出版商
Informa UK Limited
发表日期
2015-09-18
DOI
10.3109/07388551.2015.1084266
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sepsis update: management of severe sepsis and septic shock in the emergency department after the withdrawal of Xigris
- (2016) Robert S. Green et al. Canadian Journal of Emergency Medicine
- Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion protein
- (2015) Justin McCue et al. BIOLOGICALS
- Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity
- (2015) Eloïse Perot et al. THROMBOSIS RESEARCH
- MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
- (2014) Frank Behrens et al. ANNALS OF THE RHEUMATIC DISEASES
- Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality
- (2014) William C. Yang et al. BIOTECHNOLOGY PROGRESS
- The choice of mammalian cell host and possibilities for glycosylation engineering
- (2014) Michael Butler et al. CURRENT OPINION IN BIOTECHNOLOGY
- Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)
- (2014) Carol Wysham et al. DIABETES CARE
- Validation of the manufacturing process used to produce long-acting recombinant factor IX Fc fusion protein
- (2014) J. McCue et al. HAEMOPHILIA
- Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
- (2014) Kathleen M Dungan et al. LANCET
- Addition of Valproic Acid to CHO Cell Fed-Batch Cultures Improves Monoclonal Antibody Titers
- (2014) William C. Yang et al. MOLECULAR BIOTECHNOLOGY
- Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems
- (2013) Yoram Tekoah et al. BIOSCIENCE REPORTS
- Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
- (2013) J. Mahlangu et al. BLOOD
- Trends in Translational Medicine and Drug Targeting and Delivery: New Insights on an Old Concept—Targeted Drug Delivery with Antibody–Drug Conjugates for Cancers
- (2013) J.Y. Rodney et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A simple, robust and highly efficient transient expression system for producing antibodies
- (2013) Tom Vink et al. METHODS
- Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B
- (2013) Jerry S. Powell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Production of Recombinant Therapeutic Proteins in Human Cells: Current Achievements and Future Perspectives
- (2013) Virgínia Picanco-Castro et al. PROTEIN AND PEPTIDE LETTERS
- Use of baculovirus expression system for generation of virus-like particles: Successes and challenges
- (2013) Fuxiao Liu et al. PROTEIN EXPRESSION AND PURIFICATION
- Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase
- (2012) Ari Zimran et al. AMERICAN JOURNAL OF HEMATOLOGY
- Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease
- (2012) Hadhami Ben Turkia et al. AMERICAN JOURNAL OF HEMATOLOGY
- Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation
- (2012) Darius Ghaderi et al. Biotechnology & Genetic Engineering Reviews
- Analysis of dynamic changes in the proteome of a Bcl-XL overexpressing Chinese hamster ovary cell culture during exponential and stationary phases
- (2012) Tyler Carlage et al. BIOTECHNOLOGY PROGRESS
- Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs
- (2012) J. A. Dumont et al. BLOOD
- Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
- (2012) J. S. Powell et al. BLOOD
- The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics
- (2012) Elisabeth Casademunt et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Effect of hypothermic temperatures on production of rabies virus glycoprotein by recombinant Drosophila melanogaster S2 cells cultured in suspension
- (2012) Nickeli Rossi et al. JOURNAL OF BIOTECHNOLOGY
- Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein
- (2012) R. T. PETERS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Drotrecogin Alfa (Activated) in Adults with Septic Shock
- (2012) V. Marco Ranieri et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Multi-Omics Analysis of Recombinant Protein Production in Hek293 Cells
- (2012) Stefanie Dietmair et al. PLoS One
- Human cells: New platform for recombinant therapeutic protein production
- (2012) Kamilla Swiech et al. PROTEIN EXPRESSION AND PURIFICATION
- Human hepatoma cell line HuH-7 is an effective cellular system to produce recombinant factor IX with improved post-translational modifications
- (2012) Nathalie Enjolras et al. THROMBOSIS RESEARCH
- Characterisation of the post-translational modifications of a novel, human cell line-derived recombinant human factor VIII
- (2012) Christoph Kannicht et al. THROMBOSIS RESEARCH
- CHO cells in biotechnology for production of recombinant proteins: current state and further potential
- (2011) Jee Yon Kim et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
- (2011) A. D. Shapiro et al. BLOOD
- Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII
- (2011) Kamilla Swiech et al. BMC BIOTECHNOLOGY
- The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
- (2011) Xun Xu et al. NATURE BIOTECHNOLOGY
- Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing
- (2010) Andreas Berting et al. BIOTECHNOLOGY AND BIOENGINEERING
- Prolonged activity of factor IX as a monomeric Fc fusion protein
- (2010) R. T. Peters et al. BLOOD
- Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice
- (2010) Massimo Franchini et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
- (2010) Wolfgang Glaesner et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Erythropoietin Produced in a Human Cell Line (Dynepo) Has Significant Differences in Glycosylation Compared with Erythropoietins Produced in CHO Cell Lines
- (2010) Zahra Shahrokh et al. MOLECULAR PHARMACEUTICS
- Chinese hamster ovary cells can produce galactose-α-1,3-galactose antigens on proteins
- (2010) Carlos J Bosques et al. NATURE BIOTECHNOLOGY
- Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
- (2010) Darius Ghaderi et al. NATURE BIOTECHNOLOGY
- Expression systems for therapeutic glycoprotein production
- (2009) Yves Durocher et al. CURRENT OPINION IN BIOTECHNOLOGY
- Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety
- (2009) Michael Beck EXPERT OPINION ON BIOLOGICAL THERAPY
- An improved manufacturing process for Xyntha/ReFacto AF
- (2009) B. KELLEY et al. HAEMOPHILIA
- Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II
- (2008) J Edmond Wraith ACTA PAEDIATRICA
- Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo)
- (2008) Esther Llop et al. ANALYTICAL BIOCHEMISTRY
- An overview of animal cell substrates for biological products
- (2008) John Petricciani et al. BIOLOGICALS
- Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells
- (2008) Martin Loignon et al. BMC BIOTECHNOLOGY
- Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection
- (2008) Gudrun Schiedner et al. BMC BIOTECHNOLOGY
- Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease
- (2008) V. Padler-Karavani et al. GLYCOBIOLOGY
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
- (2008) Christine H. Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
- First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity
- (2008) A.B.H. Bakker et al. VACCINE
- Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity
- (2007) M.J.E. Havenga et al. BIOTECHNOLOGY AND BIOENGINEERING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now